Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1999 Jan;229(1):84–90. doi: 10.1097/00000658-199901000-00011

Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B and C cirrhosis.

N Nagasue 1, H Kohno 1, M Tachibana 1, A Yamanoi 1, H Ohmori 1, O N El-Assal 1
PMCID: PMC1191612  PMID: 9923804

Abstract

OBJECTIVE: To evaluate prognostic factors after resection of hepatocellular carcinoma (HCC) in patients with Child-Turcotte class B and C cirrhosis. SUMMARY BACKGROUND DATA: Although hepatic resection remains the mainstay in the treatment of HCC and can be performed with low morbidity and mortality rates in patients without cirrhosis, its role is poorly defined for patients with severe cirrhosis. METHODS: From 1986 to 1996, partial hepatectomy was performed for HCC in 63 patients with Child-Turcotte class B (n = 46) and C (n = 17) cirrhosis. There were 46 men and 17 women, with an average age of 61.2 years (range 35 to 79 years). Associated conditions were diabetes mellitus in 45, esophageal varices in 32, severe hypersplenism in 26, cholelithiasis in 13, gastroduodenal ulcer in 6, and hiatal hernia, gastric lymphoma, splenic abscess, and pancreatic cyst each in 1. Concomitant surgical procedures were performed for most of these conditions. RESULTS: Major complications occurred in 17 patients (27%), six (9.5%) of whom died within 1 month after surgery. The overall in-hospital death rate was 14.3%. Liver failure and intraabdominal sepsis were mostly fatal complications. The overall and disease-free survival rates, respectively, were 70.2% and 64.5% at 1 year, 43.5% and 23.8% at 3 years, and 21.4% and 14.9% at 5 years. Multivariate analysis with the Cox regression model revealed that favorable factors for survival were Child class B, no transcatheter arterial embolization before surgery, young age, and low alanine aminotransferase (ALT) level before surgery. CONCLUSIONS: Hepatic resection can provide a favorable result in young patients with HCC complicating Child class B cirrhosis with low hepatitis activity, but transcatheter arterial embolization before surgery should be avoided in such patients.

Full text

PDF
84

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anthony P. P., Ishak K. G., Nayak N. C., Poulsen H. E., Scheuer P. J., Sobin L. H. The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol. 1978 May;31(5):395–414. doi: 10.1136/jcp.31.5.395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Balsells J., Charco R., Lazaro J. L., Murio E., Vargas V., Allende E., Margarit C. Resection of hepatocellular carcinoma in patients with cirrhosis. Br J Surg. 1996 Jun;83(6):758–761. doi: 10.1002/bjs.1800830610. [DOI] [PubMed] [Google Scholar]
  3. Barbara L., Benzi G., Gaiani S., Fusconi F., Zironi G., Siringo S., Rigamonti A., Barbara C., Grigioni W., Mazziotti A. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology. 1992 Jul;16(1):132–137. doi: 10.1002/hep.1840160122. [DOI] [PubMed] [Google Scholar]
  4. Belghiti J., Panis Y., Farges O., Benhamou J. P., Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg. 1991 Aug;214(2):114–117. doi: 10.1097/00000658-199108000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bismuth H., Chiche L., Adam R., Castaing D., Diamond T., Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg. 1993 Aug;218(2):145–151. doi: 10.1097/00000658-199308000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bismuth H., Chiche L., Castaing D. Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: experience with 68 liver resections. World J Surg. 1995 Jan-Feb;19(1):35–41. doi: 10.1007/BF00316977. [DOI] [PubMed] [Google Scholar]
  7. Bismuth H., Houssin D., Ornowski J., Meriggi F. Liver resections in cirrhotic patients: a Western experience. World J Surg. 1986 Apr;10(2):311–317. doi: 10.1007/BF01658152. [DOI] [PubMed] [Google Scholar]
  8. Bismuth H., Morino M., Sherlock D., Castaing D., Miglietta C., Cauquil P., Roche A. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg. 1992 Apr;163(4):387–394. doi: 10.1016/0002-9610(92)90039-t. [DOI] [PubMed] [Google Scholar]
  9. Castells A., Bruix J., Bru C., Fuster J., Vilana R., Navasa M., Ayuso C., Boix L., Visa J., Rodés J. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology. 1993 Nov;18(5):1121–1126. [PubMed] [Google Scholar]
  10. Christensen E., Schlichting P., Fauerholdt L., Gluud C., Andersen P. K., Juhl E., Poulsen H., Tygstrup N. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology. 1984 May-Jun;4(3):430–435. doi: 10.1002/hep.1840040313. [DOI] [PubMed] [Google Scholar]
  11. Conn H. O. A peek at the Child-Turcotte classification. Hepatology. 1981 Nov-Dec;1(6):673–676. doi: 10.1002/hep.1840010617. [DOI] [PubMed] [Google Scholar]
  12. D'Amico G., Morabito A., Pagliaro L., Marubini E. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci. 1986 May;31(5):468–475. doi: 10.1007/BF01320309. [DOI] [PubMed] [Google Scholar]
  13. Ebara M., Ohto M., Shinagawa T., Sugiura N., Kimura K., Matsutani S., Morita M., Saisho H., Tsuchiya Y., Okuda K. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients. Gastroenterology. 1986 Feb;90(2):289–298. doi: 10.1016/0016-5085(86)90923-6. [DOI] [PubMed] [Google Scholar]
  14. Farmer D. G., Rosove M. H., Shaked A., Busuttil R. W. Current treatment modalities for hepatocellular carcinoma. Ann Surg. 1994 Mar;219(3):236–247. doi: 10.1097/00000658-199403000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fujio N., Sakai K., Kinoshita H., Hirohashi K., Kubo S., Iwasa R., Lee K. C. Results of treatment of patients with hepatocellular carcinoma with severe cirrhosis of the liver. World J Surg. 1989 Mar-Apr;13(2):211–218. doi: 10.1007/BF01658403. [DOI] [PubMed] [Google Scholar]
  16. Garrison R. N., Cryer H. M., Howard D. A., Polk H. C., Jr Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg. 1984 Jun;199(6):648–655. doi: 10.1097/00000658-198406000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ginés P., Quintero E., Arroyo V., Terés J., Bruguera M., Rimola A., Caballería J., Rodés J., Rozman C. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987 Jan-Feb;7(1):122–128. doi: 10.1002/hep.1840070124. [DOI] [PubMed] [Google Scholar]
  18. Gozzetti G., Mazziotti A., Cavallari A., Bellusci R., Bolondi L., Grigioni W., Bragaglia R., Grazi G. L., De Raffele E. Clinical experience with hepatic resections for hepatocellular carcinoma in patients with cirrhosis. Surg Gynecol Obstet. 1988 Jun;166(6):503–510. [PubMed] [Google Scholar]
  19. Iwatsuki S., Gordon R. D., Shaw B. W., Jr, Starzl T. E. Role of liver transplantation in cancer therapy. Ann Surg. 1985 Oct;202(4):401–407. doi: 10.1097/00000658-198510000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Iwatsuki S., Starzl T. E. Personal experience with 411 hepatic resections. Ann Surg. 1988 Oct;208(4):421–434. doi: 10.1097/00000658-198810000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kleber G., Sauerbruch T., Ansari H., Paumgartner G. Prediction of variceal hemorrhage in cirrhosis: a prospective follow-up study. Gastroenterology. 1991 May;100(5 Pt 1):1332–1337. [PubMed] [Google Scholar]
  22. Lai E. C., Fan S. T., Lo C. M., Chu K. M., Liu C. L., Wong J. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg. 1995 Mar;221(3):291–298. doi: 10.1097/00000658-199503000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lau H., Man K., Fan S. T., Yu W. C., Lo C. M., Wong J. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg. 1997 Sep;84(9):1255–1259. [PubMed] [Google Scholar]
  24. Lencioni R., Bartolozzi C., Caramella D., Paolicchi A., Carrai M., Maltinti G., Capria A., Tafi A., Conte P. F., Bevilacqua G. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients. Cancer. 1995 Nov 15;76(10):1737–1746. doi: 10.1002/1097-0142(19951115)76:10<1737::aid-cncr2820761010>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  25. Livraghi T., Giorgio A., Marin G., Salmi A., de Sio I., Bolondi L., Pompili M., Brunello F., Lazzaroni S., Torzilli G. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology. 1995 Oct;197(1):101–108. doi: 10.1148/radiology.197.1.7568806. [DOI] [PubMed] [Google Scholar]
  26. Majno P. E., Adam R., Bismuth H., Castaing D., Ariche A., Krissat J., Perrin H., Azoulay D. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg. 1997 Dec;226(6):688–703. doi: 10.1097/00000658-199712000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Mazzaferro V., Regalia E., Doci R., Andreola S., Pulvirenti A., Bozzetti F., Montalto F., Ammatuna M., Morabito A., Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996 Mar 14;334(11):693–699. doi: 10.1056/NEJM199603143341104. [DOI] [PubMed] [Google Scholar]
  28. Michel J., Suc B., Montpeyroux F., Hachemanne S., Blanc P., Domergue J., Mouiel J., Gouillat C., Ducerf C., Saric J. Liver resection or transplantation for hepatocellular carcinoma? Retrospective analysis of 215 patients with cirrhosis. J Hepatol. 1997 Jun;26(6):1274–1280. doi: 10.1016/s0168-8278(97)80462-x. [DOI] [PubMed] [Google Scholar]
  29. Nagasue N., Kohno H., Chang Y. C., Taniura H., Yamanoi A., Uchida M., Kimoto T., Takemoto Y., Nakamura T., Yukaya H. Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg. 1993 Apr;217(4):375–384. doi: 10.1097/00000658-199304000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Nagasue N., Kohno H., Uchida M. Evaluation of preoperative transcatheter arterial embolization in the treatment of resectable primary liver cancer. Semin Surg Oncol. 1993 Jul-Aug;9(4):327–331. doi: 10.1002/ssu.2980090409. [DOI] [PubMed] [Google Scholar]
  31. Ohnishi K., Yoshioka H., Ito S., Fujiwara K. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology. 1998 Jan;27(1):67–72. doi: 10.1002/hep.510270112. [DOI] [PubMed] [Google Scholar]
  32. Olthoff K. M., Millis J. M., Rosove M. H., Goldstein L. I., Ramming K. P., Busuttil R. W. Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg. 1990 Oct;125(10):1261–1268. doi: 10.1001/archsurg.1990.01410220045007. [DOI] [PubMed] [Google Scholar]
  33. Raoul J. L., Guyader D., Bretagne J. F., Heautot J. F., Duvauferrier R., Bourguet P., Bekhechi D., Deugnier Y. M., Gosselin M. Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma. Hepatology. 1997 Nov;26(5):1156–1161. doi: 10.1002/hep.510260511. [DOI] [PubMed] [Google Scholar]
  34. Ringe B., Pichlmayr R., Wittekind C., Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg. 1991 Mar-Apr;15(2):270–285. doi: 10.1007/BF01659064. [DOI] [PubMed] [Google Scholar]
  35. Romani F., Belli L. S., Rondinara G. F., DeCarlis L., Rimoldi P., Riolo F., Bellati G., Ideo G., Belli L. The role of transplantation in small hepatocellular carcinoma complicating cirrhosis of the liver. J Am Coll Surg. 1994 Apr;178(4):379–384. [PubMed] [Google Scholar]
  36. Ruà S., Comino A., Fruttero A., Torchio P., Bouzari H., Taraglio S., Torchio B., Capussotti L. Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor. Cancer. 1996 Sep 15;78(6):1195–1202. doi: 10.1002/(SICI)1097-0142(19960915)78:6<1195::AID-CNCR5>3.0.CO;2-9. [DOI] [PubMed] [Google Scholar]
  37. Savage A. P., Malt R. A. Survival after hepatic resection for malignant tumours. Br J Surg. 1992 Oct;79(10):1095–1101. doi: 10.1002/bjs.1800791035. [DOI] [PubMed] [Google Scholar]
  38. Schwartz S. I. Biliary tract surgery and cirrhosis: a critical combination. Surgery. 1981 Oct;90(4):577–583. [PubMed] [Google Scholar]
  39. Stefanini G. F., Amorati P., Biselli M., Mucci F., Celi A., Arienti V., Roversi R., Rossi C., Re G., Gasbarrini G. Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma. An Italian experience. Cancer. 1995 May 15;75(10):2427–2434. doi: 10.1002/1097-0142(19950515)75:10<2427::aid-cncr2820751007>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  40. Uchida M., Kohno H., Kubota H., Hayashi T., Yamanoi A., Kimoto T., Ono T., Nagasue N. Role of preoperative transcatheter arterial oily chemoembolization for resectable hepatocellular carcinoma. World J Surg. 1996 Mar-Apr;20(3):326–331. doi: 10.1007/s002689900052. [DOI] [PubMed] [Google Scholar]
  41. Vauthey J. N., Klimstra D., Franceschi D., Tao Y., Fortner J., Blumgart L., Brennan M. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg. 1995 Jan;169(1):28–35. doi: 10.1016/s0002-9610(99)80106-8. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES